New product: Jemperli (dostarlimab) 500 mg concentrate for solution for infusion

This monoclonal antibody of the IgG4 isotype that binds to PD-1 receptors is licensed as monotherapy for treatment of adults with dMMR/MSI-H recurrent/advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing regimen.

electronic Medicines compendium